Newlink Genetics reported 84.99M in Current Assets for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Agenus AGEN:US $ 288.93M 1.55M
Bristol Myers Squibb BMY:US $ 30186M 65M
Capricor Therapeutics CAPR:US $ 52.62M 7.01M
Celldex Therapeutics CLDX:US $ 367.98M 22.72M
Eli Lilly And LLY:US $ 17115.2M 150.5M
Idera Pharmaceuticals IDRA:US $ 25.59M 3.77M
Intrexon XON:US $ 164.62M 9.68M
Nektar Therapeutics NKTR:US $ 665.54M 67.92M
Newlink Genetics NLNK:US 84.99M 7.66M
Prothena PRTA:US 521.29M 34.33M
Sarepta Therapeutics SRPT:US $ 2469.3M 61.65M
Vascular Biogenics VBLT:US 35.69M 10.83M
YTE INCY:US $ 3625.84M 337.75M